OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Hypoxia and Tumor Angiogenesis in the Era of Hepatocellular Carcinoma Transarterial Loco-Regional Treatments
Mario Petrillo, Francesca Patella, Filippo Pesapane, et al.
Future Oncology (2018) Vol. 14, Iss. 28, pp. 2957-2967
Closed Access | Times Cited: 79
Mario Petrillo, Francesca Patella, Filippo Pesapane, et al.
Future Oncology (2018) Vol. 14, Iss. 28, pp. 2957-2967
Closed Access | Times Cited: 79
Showing 51-75 of 79 citing articles:
Liposome-Encapsulated Zoledronate Favors Tumor Vascular Normalization and Enhances Anticancer Efficacy of Cisplatin
Xinjun Cai, Weidong Fei, Yingying Xu, et al.
AAPS PharmSciTech (2020) Vol. 21, Iss. 2
Closed Access | Times Cited: 9
Xinjun Cai, Weidong Fei, Yingying Xu, et al.
AAPS PharmSciTech (2020) Vol. 21, Iss. 2
Closed Access | Times Cited: 9
Long non‑coding RNA MIAT knockdown potentiates the therapeutic effect of transcatheter arterial embolization in liver cancer by regulating the miR‑203a/HIF‑1α axis
Jian Liu, Guangshao Cao, Jianwen Liu, et al.
Oncology Reports (2020) Vol. 44, Iss. 2, pp. 722-734
Open Access | Times Cited: 9
Jian Liu, Guangshao Cao, Jianwen Liu, et al.
Oncology Reports (2020) Vol. 44, Iss. 2, pp. 722-734
Open Access | Times Cited: 9
Identification of novel targets of miR-622 in hepatocellular carcinoma reveals common regulation of cooperating genes and outlines the oncogenic role of zinc finger CCHC-type containing 11
Anne Gaza, Valerie Fritz, Lara Malek, et al.
Neoplasia (2021) Vol. 23, Iss. 5, pp. 502-514
Open Access | Times Cited: 8
Anne Gaza, Valerie Fritz, Lara Malek, et al.
Neoplasia (2021) Vol. 23, Iss. 5, pp. 502-514
Open Access | Times Cited: 8
Treating Metastatic Brain Cancers With Stem Cells
Nadia Sadanandan, Alex Shear, Beverly Brooks, et al.
Frontiers in Molecular Neuroscience (2021) Vol. 14
Open Access | Times Cited: 8
Nadia Sadanandan, Alex Shear, Beverly Brooks, et al.
Frontiers in Molecular Neuroscience (2021) Vol. 14
Open Access | Times Cited: 8
Transarterial chemoembolization (TACE) plus apatinib vs. TACE alone for hepatocellular carcinoma
Ningjie Li, Ping Yang, Jun Fang
Clinics and Research in Hepatology and Gastroenterology (2022) Vol. 46, Iss. 9, pp. 102022-102022
Open Access | Times Cited: 6
Ningjie Li, Ping Yang, Jun Fang
Clinics and Research in Hepatology and Gastroenterology (2022) Vol. 46, Iss. 9, pp. 102022-102022
Open Access | Times Cited: 6
Assessment of VEGF and VEGF R1 serum levels in patients with neuroendocrine neoplasms before and after treatment with first-generation somatostatin analogues
Violetta Rosiek, Ksenia Janas
Endokrynologia Polska (2022) Vol. 73, Iss. 3, pp. 612-618
Open Access | Times Cited: 4
Violetta Rosiek, Ksenia Janas
Endokrynologia Polska (2022) Vol. 73, Iss. 3, pp. 612-618
Open Access | Times Cited: 4
A Leap from TACE to TACE Potentiated by Immune Response Modulation and Angiogenesis Inhibition for Patients with Intermediate-Stage Hepatocellular Carcinoma: LEAP-012 Phase 3 Randomized Control Trial Protocol
Nicholas Fidelman
CardioVascular and Interventional Radiology (2021) Vol. 45, Iss. 4, pp. 413-414
Closed Access | Times Cited: 4
Nicholas Fidelman
CardioVascular and Interventional Radiology (2021) Vol. 45, Iss. 4, pp. 413-414
Closed Access | Times Cited: 4
Short-term changes of angiogenesis factors after transarterial radioembolization in hepatocellular carcinoma patients
Hüseyin Tuğsan Ballı, Kairgeldy Aikimbaev, İsa Burak Güney, et al.
Diagnostic and Interventional Radiology (2023) Vol. 29, Iss. 5, pp. 704-709
Open Access | Times Cited: 1
Hüseyin Tuğsan Ballı, Kairgeldy Aikimbaev, İsa Burak Güney, et al.
Diagnostic and Interventional Radiology (2023) Vol. 29, Iss. 5, pp. 704-709
Open Access | Times Cited: 1
Act Local, Think Global: IR and Its Role in Immuno-Oncology in Hepatocellular Carcinoma
Pedro Luiz Serrano Usón, Tanios Bekaii‐Saab
Journal of Vascular and Interventional Radiology (2024) Vol. 35, Iss. 2, pp. 173-177
Open Access
Pedro Luiz Serrano Usón, Tanios Bekaii‐Saab
Journal of Vascular and Interventional Radiology (2024) Vol. 35, Iss. 2, pp. 173-177
Open Access
Hypoxia effect on proliferative activity of cells in orthotopic xenograft of hepatocellular carcinoma of the liver in the experiment
T.M. Kecheryukova, Vladimir S. Trifanov, A. A. Shulg, et al.
South Russian Journal of Cancer (2024) Vol. 5, Iss. 2, pp. 35-42
Open Access
T.M. Kecheryukova, Vladimir S. Trifanov, A. A. Shulg, et al.
South Russian Journal of Cancer (2024) Vol. 5, Iss. 2, pp. 35-42
Open Access
Lenvatinib in combination with transarterial chemoembolization vs. sorafenib in combination with transarterial chemoembolization for unresectable hepatocellular carcinoma: A network meta‑analysis
Yong Li, Xingyu Liu, Junning Liu, et al.
Oncology Letters (2024) Vol. 28, Iss. 2
Open Access
Yong Li, Xingyu Liu, Junning Liu, et al.
Oncology Letters (2024) Vol. 28, Iss. 2
Open Access
Efficacy and Safety of Transarterial Chemoembolization and Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib in Treating Massive Hepatocellular Carcinoma
Youbin Zheng, Zhengfang Xiao, Ligong Lu
Research Square (Research Square) (2024)
Closed Access
Youbin Zheng, Zhengfang Xiao, Ligong Lu
Research Square (Research Square) (2024)
Closed Access
Sequencing microsphere selective internal radiotherapy after external beam radiotherapy for hepatocellular carcinoma: proof of concept of a synergistic combination
Carlos Huesa‐Berral, Jack F Terry, L. L. Kunz, et al.
British Journal of Radiology (2024)
Closed Access
Carlos Huesa‐Berral, Jack F Terry, L. L. Kunz, et al.
British Journal of Radiology (2024)
Closed Access
Efficacy of Atezolizumab Plus Bevacizumab Combined with Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Real-World Study
Xiao Shen, Jin-Xing Zhang, Jin Liu, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 1993-2003
Open Access
Xiao Shen, Jin-Xing Zhang, Jin Liu, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 1993-2003
Open Access
Survival Analysis of TACE Monotherapy vs. Combination Therapy in BCLC B and C Stage Hepatocellular Carcinoma: A Retrospective Cohort Study
Chengxiang Guo, Weibo Du, Yiwen Chen, et al.
Research Square (Research Square) (2024)
Open Access
Chengxiang Guo, Weibo Du, Yiwen Chen, et al.
Research Square (Research Square) (2024)
Open Access
Comparative analysis of efficacy and safety between D-TACE + HAIC + lenvatinib and D-TACE + lenvatinib in the treatment of unresectable massive hepatocellular carcinoma
Haohao Lu, Bin Liang, Chuansheng Zheng, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
Haohao Lu, Bin Liang, Chuansheng Zheng, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
The combination of local treatment and immunotherapy
Bo Zhu, Jianguo Sun, Qingzhu Jia, et al.
Elsevier eBooks (2024), pp. 133-157
Closed Access
Bo Zhu, Jianguo Sun, Qingzhu Jia, et al.
Elsevier eBooks (2024), pp. 133-157
Closed Access
Prognostic value of splenic volume in hepatocellular carcinoma patients receiving transarterial chemoembolization
Haitao Dai, Bin Chen, Keyu Tang, et al.
Journal of Gastrointestinal Oncology (2021) Vol. 12, Iss. 3, pp. 1141-1151
Open Access | Times Cited: 3
Haitao Dai, Bin Chen, Keyu Tang, et al.
Journal of Gastrointestinal Oncology (2021) Vol. 12, Iss. 3, pp. 1141-1151
Open Access | Times Cited: 3
Formulation Comprising Arsenic Trioxide and Dimercaprol Enhances Radiosensitivity of Pancreatic Cancer Xenografts
Renyan Tang, Jianmin Zhu, Ying Liu, et al.
Technology in Cancer Research & Treatment (2021) Vol. 20
Open Access | Times Cited: 3
Renyan Tang, Jianmin Zhu, Ying Liu, et al.
Technology in Cancer Research & Treatment (2021) Vol. 20
Open Access | Times Cited: 3
Identification of a Hypoxia-Angiogenesis lncRNA Signature Participating in Immunosuppression in Gastric Cancer
Zicheng Wang, Xisong Liang, Hao Zhang, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-24
Open Access | Times Cited: 1
Zicheng Wang, Xisong Liang, Hao Zhang, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-24
Open Access | Times Cited: 1
Construction of a 3-mRNA hypoxia prognostic model to evaluate immune microenvironment in hepatocellular carcinoma
Jue Wang, Zongrui Jin, Guolin Wu, et al.
Medicine (2022) Vol. 101, Iss. 39, pp. e30589-e30589
Open Access | Times Cited: 1
Jue Wang, Zongrui Jin, Guolin Wu, et al.
Medicine (2022) Vol. 101, Iss. 39, pp. e30589-e30589
Open Access | Times Cited: 1
HCC: role of pre- and post-treatment tumor biology in driving adverse outcomes and rare responses to therapy
Sandeep Arora, Roberta Catania, Amir A. Borhani, et al.
Abdominal Radiology (2021) Vol. 46, Iss. 8, pp. 3686-3697
Closed Access | Times Cited: 1
Sandeep Arora, Roberta Catania, Amir A. Borhani, et al.
Abdominal Radiology (2021) Vol. 46, Iss. 8, pp. 3686-3697
Closed Access | Times Cited: 1
Donafenib-Loaded Callispheres Beads Embolization in a VX2 Liver Tumor: Investigating Efficacy, Safety, and Improvement of Tumor Angiogenesis After Embolization
Tongqiang Li, Qin Shi, Jiacheng Liu, et al.
Journal of Hepatocellular Carcinoma (2021) Vol. Volume 8, pp. 1525-1535
Open Access | Times Cited: 1
Tongqiang Li, Qin Shi, Jiacheng Liu, et al.
Journal of Hepatocellular Carcinoma (2021) Vol. Volume 8, pp. 1525-1535
Open Access | Times Cited: 1
Liver Cancer Interventions
Antonio Arrichiello, Letizia Di Meglio, Salvatore Alessio Angileri, et al.
Springer eBooks (2023), pp. 189-199
Closed Access
Antonio Arrichiello, Letizia Di Meglio, Salvatore Alessio Angileri, et al.
Springer eBooks (2023), pp. 189-199
Closed Access
Special focus issue: ‘innovations in diagnostic and interventional oncology’
Giampaolo Carrafiello, Luca Brunese
Future Oncology (2018) Vol. 14, Iss. 28, pp. 2889-2891
Open Access
Giampaolo Carrafiello, Luca Brunese
Future Oncology (2018) Vol. 14, Iss. 28, pp. 2889-2891
Open Access
